Last reviewed · How we verify
Intravenous patient-controlled analgesia — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Intravenous patient-controlled analgesia (Intravenous patient-controlled analgesia) — Xiaguang Duan.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intravenous patient-controlled analgesia TARGET | Intravenous patient-controlled analgesia | Xiaguang Duan | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intravenous patient-controlled analgesia CI watch — RSS
- Intravenous patient-controlled analgesia CI watch — Atom
- Intravenous patient-controlled analgesia CI watch — JSON
- Intravenous patient-controlled analgesia alone — RSS
Cite this brief
Drug Landscape (2026). Intravenous patient-controlled analgesia — Competitive Intelligence Brief. https://druglandscape.com/ci/intravenous-patient-controlled-analgesia. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab